Related Experiment Video
Updated: Sep 25, 2025

Effective Analysis of Human Exposure Conditions with Body-worn Dosimeters in the 2.4 GHz Band
Published on: May 2, 2018
Waiting time from identification to recognition an occupational disease in Spain
Ariadna Pelegrí1, Consol Serra2, José M Ramada2
1CiSAL-Centre of Research in Occupational Health, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Objective:
To estimate the waiting time since a suspected an occupational disease (OD) is identified, notified and recognized in Spain.
Method:
A series of 34 patients attended at Occupational Diseases Unit (ODU) of Hospital del Mar in Barcelona were follow up since their identification until final resolution by the National Institute of Social Security (INSS). Median, and 25 and 75 percentiles (interquartile range [IQR]) were calculated in weeks by total time (n=27), ODU time (n=34), patient time (n=31) and INSS time (n=27).
Results:
Total time was 51 weeks (IQR: 33.6 and 122.6), of which 42 weeks (17.6-99.5) corresponded to the waiting period at the INSS.
Conclusions:
The disproportionately long waiting time since INSS receives a case could impact on the under-recognition of OD. Urgent improvement of the administrative process is needed to reduce the patient waiting time for the recognition of OD.
Related Concept Videos
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
Hazard Rate
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

